Year |
Citation |
Score |
2022 |
Hill MD, Fang H, Norris D, Delucca GV, Huang H, DeBenedetto M, Quesnelle C, Schmitz WD, Tokarski JS, Sheriff S, Yan C, Fanslau C, Haarhoff Z, Huang C, Kramer M, et al. Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties. Acs Medicinal Chemistry Letters. 13: 1165-1171. PMID 35859878 DOI: 10.1021/acsmedchemlett.2c00219 |
0.482 |
|
2010 |
Schmitz WD, Brenner AB, Bronson JJ, Ditta JL, Griffin CR, Li YW, Lodge NJ, Molski TF, Olson RE, Zhuo X, Macor JE. 5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 3579-83. PMID 20483614 DOI: 10.1016/j.bmcl.2010.04.121 |
0.584 |
|
2010 |
Hartz RA, Ahuja VT, Schmitz WD, Molski TF, Mattson GK, Lodge NJ, Bronson JJ, Macor JE. Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 1890-4. PMID 20176478 DOI: 10.1016/j.bmcl.2010.01.129 |
0.587 |
|
2009 |
Hartz RA, Ahuja VT, Arvanitis AG, Rafalski M, Yue EW, Denhart DJ, Schmitz WD, Ditta JL, Deskus JA, Brenner AB, Hobbs FW, Payne J, Lelas S, Li YW, Molski TF, et al. Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists. Journal of Medicinal Chemistry. 52: 4173-91. PMID 19552437 DOI: 10.1021/Jm900301Y |
0.595 |
|
2009 |
Hartz RA, Ahuja VT, Rafalski M, Schmitz WD, Brenner AB, Denhart DJ, Ditta JL, Deskus JA, Yue EW, Arvanitis AG, Lelas S, Li YW, Molski TF, Wong H, Grace JE, et al. In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. Journal of Medicinal Chemistry. 52: 4161-72. PMID 19552436 DOI: 10.1021/Jm900302Q |
0.582 |
|
2005 |
Schmitz WD, Denhart DJ, Brenner AB, Ditta JL, Mattson RJ, Mattson GK, Molski TF, Macor JE. Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs). Bioorganic & Medicinal Chemistry Letters. 15: 1619-21. PMID 15745809 DOI: 10.1016/j.bmcl.2005.01.059 |
0.514 |
|
Show low-probability matches. |